Actively Recruiting
Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
Led by University of Turku · Updated on 2025-08-24
110
Participants Needed
4
Research Sites
307 weeks
Total Duration
On this page
Sponsors
U
University of Turku
Lead Sponsor
T
Turku University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to cast light on the highly complex etiology and cellular landscape of hip osteoarthritis by utilising single-cell and spatial omics.
CONDITIONS
Official Title
Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with osteoarthritis in the hip joint undergoing elective total hip arthroplasty
- Non-arthritis adult patients undergoing trauma-based emergency total hip arthroplasty as controls
- Adult patients with rheumatoid arthritis in the hip joint undergoing elective total hip arthroplasty (Rheumatoid sub-study)
You will not qualify if you...
- Body mass index (BMI) must be below 35
- Age under 18 or over 74 years
- Osteoarthritis patients may not have diabetes, rheumatoid arthritis, or metabolic syndrome
- Rheumatoid sub-study excludes the same criteria except for rheumatoid arthritis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
PET-centre, University of Turku
Turku, Southwest Finland, Finland
Active, Not Recruiting
2
Turku Bioscience, University of Turku
Turku, Southwest Finland, Finland
Active, Not Recruiting
3
Turku University Hospital
Turku, Southwest Finland, Finland
Actively Recruiting
4
Helsinki University Hospital
Espoo, Uusimaa, Finland
Actively Recruiting
Research Team
L
Lea Mikkola, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here